NEW ORLEANS, June 6, 2026 /PRNewswire/ -- Today, from the main stage at the organization's 2026 Scientific Sessions, the American Diabetes Association® (ADA) announced...
Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect earlyKetone monitoring is not yet routine in diabetes care, which may...
Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass...
•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes • Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced • Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist
New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney diseaseZHUBEI CITY, Taiwan and RALEIGH, N.C.,...
Six months after launching The Ark, Denovia is advancing financing activities, strategic partnerships, and commercial deployment plans to scale its breakthrough recycling platform into...
Six months after launching The Ark, Denovia is advancing financing activities, strategic partnerships, and commercial deployment plans to scale its breakthrough recycling platform into...
BulkQuant introduces a simplified stock quant trading tool designed to help beginners explore AI stock trading bots without coding, complex setup, or advanced strategy configuration.
BulkQuant introduces a simplified stock quant trading tool designed to help beginners explore AI stock trading bots without coding, complex setup, or advanced strategy configuration.
New clinical findings further reinforce therapeutic potential of vapendavir as targeted approach to preventing rhinovirus-driven COPD exacerbationsWASHINGTON, June 5, 2026 /PRNewswire/ -- Altesa BioSciences, a...
TOKYO, June 5, 2026 /PRNewswire/ -- Rapidus Corporation today announced that it has completed an additional funding round of 150 billion yen (equivalent to...
New UK economic analyses show improved patient outcomes and health system savings – including nearly £200 million in projected UK NHS savings over 5 years – through increased uptake of home-based peritoneal dialysis compared to in-center hemodialysis